Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis
Mary Frances McMullin(Queen's University Belfast), Bridget S. Wilkins(Royal Victoria Infirmary), Kate Ryan(Manchester Royal Infirmary), Peter J. Campbell(Wellcome Sanger Institute), Beverley J. Hunt(Guy's and St Thomas' NHS Foundation Trust), Thomas C. Pearson(Emory Healthcare), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Anthony R. Green(Wellcome/MRC Cambridge Stem Cell Institute), D. Bareford(Birmingham City Hospital), David Oscier(Royal Bournemouth Hospital), Michael I. Polkey(University of Cambridge), John T. Reilly, Éric Rosenthal(Evelina London Children's Healthcare)
Cited by 339
Related Papers
COSMIC: the Catalogue Of Somatic Mutations In Cancer
|Nucleic Acids Research|2018|5.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k